Express News | US To Stay Committed In Bringing Mpox Outbreak Under Control
Express News | Rodman & Renshaw Reiterates Buy on Emergent BioSolutions, Maintains $16 Price Target
Emergent BioSolutions Analyst Ratings
Express News | Emergent BioSolutions Inc: Will Pay $40 Mln
Morocco Reports First Mpox Case Amid Ongoing Global Outbreak
Express News | Morocco Records First Case Of Mpox
Emergent BioSolutions Awarded Research and Development Option Valued at $41.9 Million for Continued Advanced Development and Procurement of Ebanga Treatment for Ebola
BlackRock Inc. Reduces Stake in Emergent BioSolutions Inc.
Methanex, Merck And Other Big Stocks Moving Lower In Monday's Pre-Market Session
CDC Says There Have Been No Reported Cases Of Clade I Mpox In The U.S. As Of September 6; In The U.S., Clade II Mpox Is Still Circulating At Low Levels
Bavarian Nordic Stock Slides on Moderna Mpox Vaccine Study
'First Delivery Of Mpox Vaccine Doses From The Commission Arrive Today In The Democratic Republic Of Congo' - European Commission
Press Release: OHA Is Administrative Agent and Sole Lender for Emergent BioSolutions Debt Refinancing
Moderna's Experimental Mpox Vaccine Reduces Severity of Disease, Early Study Finds
Express News | Milestone Pharmaceuticals Appoints Industry Veteran Joseph Papa to Its Board of Directors
Emergent BioSolutions Secures $250M Loan and Adjusts Equity
Express News | Emergent Biosolutions Closed A New Credit Facility Agreement With Oak Hill Advisors
Express News | Emergent BioSolutions: Terminated Obligations Under Senior Term Loan Facility and Revolving Credit Facility Under Prior Credit Agreement
Emergent BioSolutions Successfully Refinances Debt & Further Strengthens Financial Profile
12 Health Care Stocks Moving In Monday's Pre-Market Session